PetMed Express Inc has a consensus price target of $17.63, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from Lake Street, Morgan Stanley, and Morgan Stanley on June 12, 2024, June 12, 2024, and November 16, 2023. With an average price target of $5.67 between Lake Street, Morgan Stanley, and Morgan Stanley, there's an implied 41.54% upside for PetMed Express Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/12/2024 | Buy Now | 74.85% | Lake Street | Ryan Meyers | $9 → $7 | Maintains | Buy | Get Alert |
06/12/2024 | Buy Now | -12.58% | Morgan Stanley | Erin Wright | $6.5 → $3.5 | Maintains | Underweight | Get Alert |
11/16/2023 | Buy Now | 62.36% | Morgan Stanley | Erin Wright | $7 → $6.5 | Maintains | Underweight | Get Alert |
10/31/2023 | Buy Now | 74.85% | Morgan Stanley | Erin Wright | $10 → $7 | Maintains | Underweight | Get Alert |
10/19/2023 | Buy Now | 149.78% | Morgan Stanley | Erin Wright | $17 → $10 | Maintains | Underweight | Get Alert |
07/27/2023 | Buy Now | 324.63% | Morgan Stanley | Erin Wright | $17 → $17 | Reiterates | Underweight → Underweight | Get Alert |
05/25/2023 | Buy Now | 399.56% | Lake Street | Ryan Meyers | → $20 | Initiates | → Buy | Get Alert |
03/23/2023 | Buy Now | 324.63% | Morgan Stanley | Erin Wright | $18 → $17 | Maintains | Underweight | Get Alert |
11/08/2022 | Buy Now | 349.61% | Morgan Stanley | Erin Wright | $19 → $18 | Maintains | Underweight | Get Alert |
07/26/2022 | Buy Now | 374.58% | Morgan Stanley | Erin Wright | $20 → $19 | Maintains | Underweight | Get Alert |
05/10/2022 | Buy Now | 399.56% | Morgan Stanley | Erin Wright | $21 → $20 | Maintains | Underweight | Get Alert |
01/25/2022 | Buy Now | 424.54% | Morgan Stanley | Erin Wright | $25 → $21 | Maintains | Underweight | Get Alert |
01/20/2022 | Buy Now | 699.3% | Sidoti & Co. | Anthony Lebiedzinski | → $32 | Upgrade | Neutral → Buy | Get Alert |
11/18/2021 | Buy Now | 524.45% | Morgan Stanley | Erin Wright | — | Initiates | → Underweight | Get Alert |
10/01/2021 | Buy Now | 599.39% | Jefferies | Stephanie Wissink | — | Initiates | → Hold | Get Alert |
The latest price target for PetMed Express (NASDAQ:PETS) was reported by Lake Street on June 12, 2024. The analyst firm set a price target for $7.00 expecting PETS to rise to within 12 months (a possible 74.85% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for PetMed Express (NASDAQ:PETS) was provided by Lake Street, and PetMed Express maintained their buy rating.
The last upgrade for PetMed Express Inc happened on January 20, 2022 when Sidoti & Co. raised their price target to $32. Sidoti & Co. previously had a neutral for PetMed Express Inc.
There is no last downgrade for PetMed Express.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PetMed Express, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PetMed Express was filed on June 12, 2024 so you should expect the next rating to be made available sometime around June 12, 2025.
While ratings are subjective and will change, the latest PetMed Express (PETS) rating was a maintained with a price target of $9.00 to $7.00. The current price PetMed Express (PETS) is trading at is $4.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.